SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial (RILY) is trending after filing its overdue quarterly reports, which revealed strong financial performance and restored NASDAQ compliance, effectively dismantling the bearish bankruptcy thesis. This has ignited fervent community discussion and high anticipation for a powerful short squeeze, given the substantial short interest and low float, with many investors expecting significant upward price movement.

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is experiencing significant attention following its strategic partnership with Crypto.com to launch event-based prediction markets in the U.S., a sector projected to reach a trillion-dollar valuation. The community is actively discussing the stock's low float and massive trading volume, with many anticipating a multi-day rally and potential for further parabolic moves as shorts face pressure from this major crypto-adjacent catalyst.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as its Optical Interposer technology gains significant attention for solving critical bottlenecks in AI and data center optical interconnects through efficient passive alignment. Community sentiment is highly optimistic, anticipating major catalysts like production orders and key partnerships, even as unusual market activity and high call option volume spark further discussion.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is trending intensely amid a powerful rally, driven by discussions around surging physical demand, significantly higher silver prices in Asian markets, and reports of the US Mint halting sales. Community members are passionately debating whether this parabolic move is a sustainable repricing due to industrial demand and supply deficits or a speculative bubble poised for a sharp correction, with many anticipating continued upward momentum or a significant pullback.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending due to a widespread cellular and data service outage affecting a large number of customers across various regions, leading to significant community frustration over the lack of connectivity and reliability. Users are actively discussing the service disruption and its potential causes, ranging from technical issues to speculative cyberattacks, alongside calls for extensive customer compensation. Investors are debating the incident's impact on the stock's valuation, with many anticipating a decline while others point to the company's dividend appeal as a factor for long-term holders.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor (TSM) is a major trending topic, driven by high anticipation for its upcoming earnings report amidst widespread expectations of strong performance fueled by insatiable AI chip demand. Community discussion also centers on a potential U.S.-Taiwan trade deal, which could see TSM expanding its Arizona fab presence for reduced tariffs. While many anticipate robust results, some investors are weighing geopolitical risks and the impact of significant capital expenditures on future margins.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is surging following a multi-year, nine-figure defense contract with Sweden and strong Q3 earnings that beat estimates and raised guidance. Community sentiment is highly bullish, driven by increasing institutional ownership, the strategic Project Suncatcher partnership with Alphabet, and expanding demand for space-based data and intelligence solutions within a rapidly growing sector.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is trending following strong financial performance, including better-than-expected earnings and raised guidance, coupled with promising early clinical data for its IRAK1/4 inhibitor in myelodysplastic syndrome. The community is actively discussing the company's significant undervaluation, growing cash reserves, and the potential for a short squeeze or a strategic acquisition amidst an active biotech M&A environment.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The tech-heavy Nasdaq is experiencing heightened volatility due to escalating US-Iran geopolitical tensions and the Supreme Court's delayed tariff ruling, fueling market uncertainty. Community sentiment is sharply divided, with many anticipating a "V" shaped recovery on dips, while others observe a notable rotation of funds from mega-cap tech into small-cap stocks ahead of the imminent earnings season. Despite broader pressures, significant AI partnerships, like that between Alphabet and NVIDIA, continue to highlight underlying innovation within the sector.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver ($AGQ) is trending amid robust demand, driven by its critical role in clean energy and EV technologies, alongside tightening supply from imminent export restrictions in China. This backdrop fuels intense community discussion, with many anticipating a parabolic surge to rebalance the historic gold-to-silver ratio, while others caution against overbought conditions and potential volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates

Myomo (MYO) delivered earnings and revenue surprises of +18.18% and +8.74%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates

Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of +10.31% and +6.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Shares of Myomo plunged 42% in after-hours trading Monday after the maker of wearable medical robotics cut its 2025 revenue forecast and reported a bigger-than-expected loss in the second quarter (Q2).The company now sees full-year revenue of $40 million to $42 million, compared with prior guidance of $50 million to $53 million, and attributed the downward revision to lower-than-expected operating trends. It also sees third-quarter revenue of $9.5 million to $10 million.Revenue for the three months ended June 30 rose 28% from a year earlier to $9.7 million, above the Koyfin analyst estimate of $9.15 million. However, the company’s losses widened.&nbsp;Adjusted EBITDA loss was $4 million, missing analysts’ expectations of a $3.82 million loss. The company reported a net loss of $4.6 million, compared with expectations for a loss of $4.33 million in EBIT.&nbsp;Earnings per share were a loss of $0.11 per share, in line with estimates, on a GAAP basis.More than half of Q2 revenue came from Medicare Part B patients, helped by higher unit volumes and average selling prices.&nbsp;However, key forward indicators weakened: orders and insurance authorizations slipped 3% to 207 units, backlog fell 18% to 230 units, and gross margin narrowed to 62.7% from 70.8% due to higher material and overhead costs.CEO Paul R. Gudonis said performance was impacted by lower-quality leads resulting from changes to digital advertising, weaker conversion rates to pipeline additions and orders, and a cycle time issue where 40% to 50% of quarterly pipeline additions originate from leads generated more than a year prior.&nbsp;He noted that patient response, clinical profiles, and a stronger focus on outcomes were leading to more candidates being ruled ineligible for the MyoPro device.&nbsp;Much of the company’s 2025 advertising spend, he added, is expected to yield new patients in 2026 and beyond; however, recent actions and sustained ad spending are also expected to help improve operating metrics sooner.Operating expenses surged 65% to $10.6 million, driven by higher payroll, engineering costs, and a 162% increase in advertising outlays.&nbsp;Cash used in operations increased to $8.9 million from $1.9 million a year earlier, with non-recurring outflows, including $2.9 million in incentive payments and delayed insurance reimbursements, contributing to the shortfall.To curb costs, Myomo reduced its workforce by 8% in July and is scaling back spending on outside services, targeting at least $2 million in annual cash savings. The company ended the quarter with $15.5 million in cash, cash equivalents, and short-term investments, bolstered by $4 million in new borrowings.On Stocktwits, retail sentiment for Myomo was ‘extremely bullish’ early Tuesday amid a 4,700% surge in 24-hour message volume.<a href="https://stocktwits.com/symbol/MYO">Myomo’s stock</a> has declined by 72.7% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Myomo logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Medical Device Maker Myomo’s Stock Crashed 42% In After-Hours Trading

The wearable medical robotics maker slashed its 2025 revenue forecast and posted a wider-than-expected quarterly loss due to weaker lead quality, slower conversions, and rising costs.

Equity

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo (MYO) delivered earnings and revenue surprises of 0.00% and +6.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?

Capricor (CAPR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans’ administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.

Myomo Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

MYO
Myomo Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MYO News

MYOMyomo Inc